|
- FDA Panel Gives Nod to Blood Test for Colon Cancer - HealthDay
FRIDAY, May 24, 2024 (HealthDay News) -- A U S Food and Drug Administration advisory panel on Thursday recommended the approval of a new blood test that can spot colon cancer The panel voted 7-2 that the benefits outweigh the risks when using the Guardant Health's Shield test for colon cancer
- Stories and Perspectives - Guardant Health
Stay updated with the latest news and stories on Guardant Health Explore more for comprehensive coverage and news insights
- Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok
Shares of Guardant Health were up 8% Friday morning after an advisory panel to the U S Food and Drug Administration endorsed the company’s blood test to detect colorectal cancer
- Guardant Health, Inc. - Press Releases
At Guardant Health Inc , we promise to treat your data with respect and will not share your information with any third party You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below If you experience any issues with this process, please contact us for further assistance
- Guardant in the News Archives - Guardant Health
May 30, 2024 TIME100 Most Influential Companies 2024: Guardant Health May 23, 2024 F D A Panel Endorses Safety of Colon-Cancer Blood Test May 13, 2024 Guardant Health Preps for FDA Advisory Panel Review of its Blood-Based Colorectal Cancer Screening Test April 17, 2024 Leveling the Health Care Playing Field through Emerging Technology April 4
- Press Releases - Guardant Health
Explore the latest press releases from Guardant Health Stay informed about our groundbreaking advancements in healthcare biotechnology
- Guardant Health Named to TIME100 Most Influential Companies
Guardant’s Impact, Innovation, Ambition, and Success Contributed to the Recognition Guardant Health, Inc (NASDAQ:GH), a leading precision oncology company, today announced its inclusion in the fourth-annual TIME100 Most Influential Companies list, highlighting companies making an extraordinary impact around the world TIME solicited nominations across sectors, and polled its global network
- cofrend - 20th WCNDT 2024 - KOREA
20th WCNDT 2024 - KOREA The Organizing Committee of the 20th World Conference on Non-Destructive Testing (20th WCNDT) has made the difficult decision to postpone the conference after careful consideration and in close consultation with ICNDT
|
|
|